News Channels

03 May 2017 Genkyotex Announces FDA Approval of IND for Phase 2 Trial of GKT831 in Patients with Primary Biliary Cholangitis
03 May 2017 Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option Agreement in MiNA Therapeutics
03 May 2017 TxCell and Inserm collaborate to develop new CAR-Tregs in transplantation and multiple sclerosis
03 May 2017 Magenta Therapeutics Advances Stem Cell Transplantation Strategy with $50 Million Series B Financing, Licensing of Clinical-Stage Stem Cell Expansion Program and Strategic Partnership with Be The Match BioTherapies
03 May 2017 bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies
03 May 2017 Pieris Pharmaceuticals and AstraZeneca Collaborate to Develop and Commercialize Anticalin-Based Inhaled Treatments for Respiratory Diseases
03 May 2017 VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
03 May 2017 Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research and Development Day
03 May 2017 ZIOPHARM Oncology Announces FDA Acceptance of IND for CD33-Specific CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia
03 May 2017 First ever evidence of treatment-induced reduction in HIV reservoirs: ABX464, ABIVAX’ lead drug candidate, impacted HIV blood reservoir in a Phase IIa clinical trial (ABX464-004)
02 May 2017 Teneobio’s Next Generation T Cell Redirection Antibody Platform for Cancer Biotherapeutics Offers Prospects of Reducing Cytokine Release
02 May 2017 TESARO Announces Submission of Investigational New Drug Application for Anti-LAG Antibody TSR-033 to the U.S. FDA
02 May 2017 Celyad grants to Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents
02 May 2017 Ampio Initiates Pivotal Trial of Ampion
02 May 2017 Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Results from Long-term Phase 3 Safety Study of CAM2038
02 May 2017 Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors
02 May 2017 NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm
02 May 2017 Otsuka and Lundbeck Announce Results of Brexpiprazole on Symptoms of Agitation Related to Alzheimer’s-Type Dementia
02 May 2017 Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia
02 May 2017 Revance Provides Update on Phase 2 Program for RT002 Injectable in the Management of Plantar Fasciitis

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top